Clinical Trial Update: Natural Killer(NK) Cell Therapy for Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating allogeneic natural killer cell therapy for acute myeloid leukemia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Allogeneic natural killer cell therapy (Allogeneic NK cell therapy)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: AML, Adult | Phase 1 | Status: TERMINATED